🇺🇸 FDA
Pipeline program

Neoadjuvant chemotherapy

OIT415

Phase 1 small_molecule completed

Quick answer

Neoadjuvant chemotherapy for Squamous Cell Carcinoma of Oral Cavity is a Phase 1 program (small_molecule) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).

Program details

Company
Hospital Authority, Hong Kong
Indication
Squamous Cell Carcinoma of Oral Cavity
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials